Coronary Stent Market is expected to expand at a CAGR of 14.0% over the forecast period 2016–2026

India coronary stents market, valued at US$ 481 Mn in 2015, is expected to reach US$ 531 Mn in revenues by 2016-end, according to a new research report by Future Market Insights. The report titled, “Coronary Stents Market: India Industry Analysis and Opportunity Assessment, 2016-2026” projects the market to increase at 14% CAGR through 2026 and surpass US$ 1.8 Bn in revenues.

Demand for coronary stents is expected to be driven by government initiatives to offer better healthcare amenities. Capping of coronary stents prices, increase in geriatric population, and increasing number of PCI procedure to treat CHD are other key factors anticipated to fuel demand for coronary stents during the forecast period.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-IN-1485

Easing of norms such as exemptions in direct taxes, while allowing 100 percent FDI in medical devices segment under the automatic route is expected to encourage entry of foreign players in the healthcare sector in the near future.

Increasing prevalence of diabetes is high among the ageing population in the country. In 2014, 43.2% of the sampled population in the country was aware about diabetes and related treatment options. Over the last few years, number of PCI procedures have increased in India due to increase in prevalence of CHD.

Browse the full “Coronary Stents Market: India Industry Analysis and Opportunity Assessment, 2016 – 2026” market research report at https://www.futuremarketinsights.com/reports/india-coronary-stent-market

India coronary stents market is segmented on the basis of product type, raw material and end-use.

On the basis of product type, the market has been segmented into Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bioresorbable Vascular Stent (BVS). Drug Eluting Stent segment is expected to register impressive CAGR of 14.0% during the forecast period.

On the basis of raw material, the market is segmented into cobalt-chromium, stainless steel, platinum-chromium, nickel-titanium and polymer. Currently, demand for cobalt-chromium is the highest, followed by platinum-chromium.

On the basis of end use, India coronary stents market is segmented into hospitals, ambulatory surgical centres and cardiac catheterization laboratories. By end use, hospitals segment is expected to witness fastest growth during the forecast period.

The key players profiled in FMI’s report include Abbott Laboratories, Medtronic, Inc., Biosensors Inc., and Boston Scientific Inc. The report also identifies company-specific strategies related to product development, market consolidation initiatives and analysis of their specific strengths, weaknesses, opportunities and threats.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-IN-1485

Key Segments

Product Type

  • Drug Eluting Stent
  • Bare Metal Stent
  • Bioresorbable Vascular Stent

Raw Material Type

  • Cobalt Chromium
  • Stainless Steel
  • Platinum Chromium
  • Polymer

End User

  •   Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Catheterization Laboratories

Critical Care Information Systems Market SWOT Analysis, Business Growth Opportunities by Top Companies, Future Challenges, Competitive Strategies and Forecast to 2027

Critical care information systems are used to help manage the large amount of data generated in an intensive care unit every day. Obtaining, synchronizing, assimilating, and evaluating patient data is very difficult because of incompatibilities among monitoring equipment, the absence of standard data formatting and proprietary limitations from industry. The intensive care units are a specialized section of a hospital containing the equipment, medical and nursing staff, monitoring and life support devices necessary to provide continuous care to patients that are severely ill and medically unstable. Information and communication technology has the potential to address many problems encountered in ICU care and managing large amounts of patient and research data and reducing medical errors.

Critical Care Information Systems Market: Drivers and Restraints

The extensive use of physiological monitoring and organ support systems in critical care ensures that these areas are already technologically rich environments. This leads to a higher likelihood of acceptance of new information technology and ease in its implementation that reduces the inherent risk of information technology projects. However, clinical record keeping has been more challenging, particularly the requirement for electronic storage of a medico-legal record.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-3649

Decision support ranges in its extent and requires further development. Successful integration with other hospital systems is highly desirable but may be made more difficult by the lack of rigorous technical standards in healthcare computing. The critical care information system is fundamental to the quality improvement, research and business reporting functions. The huge amount of data, the lack of common minimal and extensive data sets, and the technical challenges of software development, all combine to make this a resource expensive venture requiring on site customization. Purchasing and implementing a critical care information system is costly in human and material resources.

Critical Care Information Systems Market: Segmentation

The critical care information system provider’s offer specialized programs to the end-users assisting in management of health plans by offering solutions to increasing costs of complexities in various treatments.

Critical Care Information Systems Market: Overview

The critical care information system has been implemented in 201 adult and pediatric Level 3 and Level 2 critical care units. The system provides an important medium for monitoring and managing the province’s critical care resources more effectively, as well as highlighting opportunities for implementing quality improvement initiatives at individual hospitals and across the LHINs.  Additionally, critical care information system supports the ventilator associated pneumonia and central line infection data collection under the ministry’s patient safety initiative. The data captured in critical information system is also used to develop quarterly reports to inform health care system improvements.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-3649

Critical Care Information Systems Market: Region-wise Outlook

Geographically, the market is segmented into North America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, Latin America, and Middle East and Africa. North America is the largest market for critical care information systems owing to extensive technological advancements in this region. Countries such as the U.S. and Canada have been successful in implementing eHealth and health in their healthcare system, which as a result will boost the market growth. Also presence of developed healthcare and IT infrastructure, promising government initiatives in executing critical care information system in the current healthcare infrastructure and constantly improving reimbursement scenario is further propelling the market growth. Followed by North America is Europe market in the critical care information system owing to enhanced digitization of the healthcare processes and implementation of telehealth in this region. Asia Pacific include the acceptance and demand for high end medical. Countries like China, Japan and India are developing countries and hence fuel the market growth for critical care information system. Countries in Latin America like as Brazil and Mexico are the regions that have significant potential for growth due to evolving medical structure in the critical care information systems.

Critical Care Information Systems Market: Key Players

Some of the major market players include Affiliated Computer Services Inc., All Scripts Healthcare Solutions, Inc., Cerner Corporation, CompuGroup Medical, Computer Sciences Corporation, iSOFT Group Limited, Picis Clinical Solutions, Inc., Optum, Inc., McKesson Corporation and Siemens Healthcare. The companies in this market are adopting various strategies like agreements, expansions, and product deployment to increase their share and create a strong position in the critical care information system market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/3649

Critical Care Information Systems Market: Segmentation

On the basis of component the critical care information systems market can be segmented into

  • Hardware
  • Software
  • Services

On the basis of deployment the critical care information systems market can be segmented into

  • On-Premise
  • Cloud-Based

On the basis of end-user the critical care information systems market can be segmented into,

  • Hospitals
  • oLevel 2 ICU’s
  • oLevel 3 ICU’s
  • Clinics
  • Nursing Homes
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Pharmacovigilance Market – Latest Scenario On Innovation, Revolutionary Opportunities & Top Consumers 2031

ESOMAR-certified company Future Market Insights (FMI) has published a report on the global pharmacovigilance market for the forecast period 2021-2031. According to the report, the market is poised to reach new heights, as pharmaceutical companies scramble to introduce new drug candidates for multiple ailments, which will result in an increase in clinical trials.

As per FMI’s analysis, the market is expected to register double-digit growth, experiencing an impressive CAGR throughout the forecast period. Historically, the market posted credible gains, surpassing US$ 6 billion in 2020, expanding at a CAGR of over 14%. Growth prospects were further heightened during the COVID-19 pandemic, as the scramble for new treatment approaches is prompting pharmaceutical companies to initiate clinical trials for the same.

Prominent pharmaceutical companies are forging long-term partnerships and service agreements with contract research organizations and business processing outsourcing units to enhance existing pharmacovigilance operations by virtue of cost reduction from drug delivery to post-marketing approvals. In April 2021, Thermo Fisher Scientific Inc. announced its plans to acquire Pharmaceutical Product Development (PPD) Inc. for a purchase price of US$ 17.4 billion, which will help enhance the latter’s pharmacovigilance portfolio expansion.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1107

Key Takeaways from FMI’s Pharmacovigilance Market Study

  • By phase of drug development, stage IV clinical trials pharmacovigilance solutions account for over 3 out of 4 applications
  • Based on method type, targeted spontaneous reporting to make maximum use of pharmacovigilance solutions
  • By service provider type, contract outsourcing to generate almost two out of five pharmacovigilance solutions uptake
  • US experiencing robust pharmacovigilance solutions providers presence amid prevalence of good PV practices
  • Forthcoming clinical trials for numerous drug candidates through 2021 to widen UK’s growth prospects
  • India to emerge as an emerging pharmacovigilance hub amid growing trends of medical operations outsourcing
  • China to experience growth on the back of recent amendments to render pharmacovigilance implementation stronger

“Rising prevalence of chronic and infectious ailments is prompting multiple pharmaceutical giants to initiate widespread clinical trials for potential drug molecules, generating a highly competitive environment and generating major revenue pools,” says the FMI analyst.

Competitive Landscape

Prominent pharmacovigilance solutions providers are relying on collaborating with prominent biopharmaceutical and pharmaceutical companies to offer their digital solutions to facilitate effective patient care solutions. Also, offering advanced solutions is another prominent strategy. Some prominent faces include F. Hoffmann- La Roche, GlaxoSmithKline Plc., Covance Inc., ICON Plc. and iGATE Corporation among others.

Covance Inc. is a prominent pharmacovigilance solutions providing, offering end-to-end PV services spanning clinical and post-marketing phases from medical contract centers to ICSRs to medical reviews to electronic regulatory submissions. The system helps track weekly, daily and monthly metrics for quality, productivity and efficiency.

In April 2020, ICON Plc. initiated efforts to enhance pharmacovigilance practices, considering the onset of COVID-19. A webinar conducted on this issue by the company called for key pharmaceutical companies to automate their workflows by installing proactive and dedicated intelligence processes, forging detailed business and continuity plans and a virtually globally distributed footprint.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1107

More Insights on the Global Pharmacovigilance Market

In its latest report, FMI offers an unbiased analysis of the global pharmacovigilance market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of phase of drug development (preclinical studies, phase I, phase II, phase III and phase IV), type of methods (spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring and EHR mining), service type provider (in-house pharmacovigilance and contract outsourcing) and region (North America, Latin America, Europe, Asia-Pacific and Middle East & Africa).

Laser Fiber In Medical Applications Market SWOT Analysis, Business Growth Opportunities by Top Companies, Future Challenges, Competitive Strategies and Forecast to 2027

Laser Fiber In Medical Applications Market Overview

Globally, the medical laser fiber market is witnessing significant growth due to the increasing preference towards non-invasive surgeries, the dependence of medicine on diagnostics procedures and the rapid development in the laser fiber technologies. The application of laser fiber has been expanding in the last few years as there is an increase in the number of market entrants in the laser fiber market. The application of laser fibers in used in diagnostic, cosmetics, therapeutic and surgical.  In addition to this miniature instruments is been preferred in most of the healthcare setting and there has been a considerable increase in the development of these instruments. There has been a rise in the number of cosmetic procedures performed and these miniature instruments help the cosmetic surgeon perform the cosmetic surgery with more ease and perfection. The presence of various laser fiber applications such as fiber optic surgical lights, endoscopes, fiber optic dental lights, fiber optic sensors and laser fiber optics.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-3550

There has been an increase in the outpatient flow in the accident and emergency departments. Most of the patients visit to under some eye surgery. This has created a lot of work load on the hospital staff in addition to the healthcare expenditure. Moreover, there is a rising trend of people undergoing cosmetic surgery as there is increase in spending capacity along with the lesser need for surgery. In March 2017, Lumenis Ltd. announced the new arrival of Moses holmium technology. The device which was developed for lithotripsy and assures better stone dusting and stone fragmentation. OmniGuide Holdings, Inc. also launched its VELOCITY High Performance Fiber to provide precision cutting along with increased speed. Through this s technology surgeons can reduce the time taken for performing a particular procedure while maintaining the tissue preservation and micron-level thermal spread.

Geographically, laser fiber in medical applications market is segmented into regions viz. North America, Latin America, Europe, Asia Pacific and Japan, Middle East and Africa. North America and Europe region is projected to maintain its lions share over the forecast period. This is due to the rising elderly population, the increasing ophthalmic issues, the improved infrastructure and the rising development of advanced technologies in the laser fiber optics.  Asia Pacific is the fastest growing region with the presence of huge population pool and the rising disposable income. People are more aware of the procedures available which can be done without going under the knifes.

Key Players

The players in laser fiber in medical applications market Boston Scientific Corporation, C. R. Bard, Inc., Biolitec U.S. Inc, Olympus America,Cook Medical, ForTec Medical, International Medical Lasers, LEONI, LUMENIS and AngioDynamics Corporation to name a few.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-3550

The report covers exhaustive analysis on:

  • Laser Fiber in Medical Applications Market Segments
  • Laser Fiber in Medical Applications Market Dynamics
  • Laser Fiber in Medical Applications Market Size, 2016 – 2024
  • Laser Fiber in Medical Applications Market Size & Forecast 2017 to 2027
  • Laser Fiber in Medical Applications Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Laser Fiber in Medical Applications Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Laser Fiber In Medical Applications Market

Laser fiber in medical applications market has been segmented on the basis of product type, material type, specialty and region.

Based on the product type, laser fiber in medical applications market is segmented into the following:

  • Disposable laser fiber
  • Reusable laser fiber

Based on material type, the laser fiber in medical applications market is segmented into the following:

  • Thulium laser fibers
  • Holmium laser fibers
  • Others

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/3550

Based on application, the laser fiber in medical applications market is segmented into the following:

  • Dermatology
  • OB/GYN
  • Plastic Surgery
  • Urology
  • Vein Treatment
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Hyperbaric Oxygen Therapy Devices Market Size, Share Production & Consumption Analysis With Forecast To 2031

The demand for hyperbaric oxygen therapy devices has been increasing significantly with rising prevalence of wound infection and gas embolism across the globe, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global hyperbaric oxygen therapy devices market is anticipated to grow at above 9% CAGR throughout the forecast period from 2021 to 2031.

According to the report by Future Market Insights, growing incidences of ischemic stroke and diabetes has fueled the demand for hyperbaric oxygen therapy devices across the globe. According to data published by World Health Organization, around 422 Million people suffering from diabetes. Also, 1.6 million people die due to diabetes related diseases states to the study.

Diabetes becomes the breeding ground for various ailments like diabetic foot ulcer, ischemic stroke and chronic infections. Rising cases of diabetes and obesity will fuel the market growth. Hyperbaric oxygen therapy (HBOT) devices deliver 100% pure oxygen to the body tissues at 1.5 to 3 times the normal atmospheric pressure.

Excess oxygen in the blood promotes white blood cells and leucocytes to fight bacteria and promotes the secretion of stem cells for faster healing and restoring normal body function. Introduction of portable hyperbaric oxygen therapy devices and increasing awareness in medical space regarding importance and utility of multiplace HBOT, especially in wound healing will drive the market growth.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1099

In the future, the market is anticipated to grow significantly, as healthcare workers are switching towards hyperbaric oxygen therapy devices for treating soft tissue necrosis. Asia Pacific region is likely to yield highly opportunistic prospects, contributing towards the overall expansion of the market.

Key Takeaways from FMI’s Hyperbaric Oxygen Therapy Devices Market Study

  • The U.S is expected to dominate hyperbaric oxygen therapy devices market on the back of rising cases of soft tissue necrosis and increasing government funding towards modernization of healthcare infrastructure.
  • Rapidly increasing number of people suffering from anemia, especially women under reproductive age will increase hyperbaric oxygen therapy devices adoption across Russia.
  • China will offer lucrative opportunities owing to increasing prevalence of osteomyelitis in older population and advancement in healthcare system.
  • India is expected to exhibit impressive market growth owing to increase in cancer patients suffering from radiation injury and growing incidence of diabetic foot ulcers in the country.
  • Monoplace hyperbaric oxygen therapy devices will continue to encompass maximum market share owing to its low set up time and high availability.

“Rising prevalence of acute and chronic wounds coupled with diabetic foot infection will amplify sales of hyperbaric oxygen therapy devices during the forecast period,” says the FMI analyst.

Competitive Landscape

Hyperbaric oxygen therapy devices market is dominated by few global market leaders. Market leaders operating in hyperbaric oxygen therapy devices market are focusing towards employing organic market strategies to consolidate their market position.

Organic strategies include new product development and extensive research and development for product portfolio expansion. They are also working towards launching modern and cheaper medical devices to penetrate the new markets and capture maximum market share especially in emerging economies.

Some market players are employing strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels. They are also emphasizing towards faster product approvals, product development and patenting.

Prominent players operating in the hyperbaric oxygen therapy devices market are:-

  • ETC BioMedical Systems
  • Fink Engineering Pvt. Ltd.
  • Gulf Coast Hyperbarics Inc.
  • HAUX-LIFE-SUPPORT GmbH
  • Hearmec Co. Ltd.
  • Hyperbaric SAC
  • IHC Hytech B.V.
  • OxyHeal Health Group
  • Sechrist Industries, Inc.
  • SOS Medical Group, Ltd.

Request a Complete TOC of this Report with figures:  https://www.futuremarketinsights.com/toc/rep-gb-1099

More Insights on the Global Hyperbaric Oxygen Therapy Devices Market

In its latest report, FMI offers an unbiased analysis of the global hyperbaric oxygen therapy devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (mono-place HBOT devices, multi-place HBOT devices, and topical HBOT devices) and application (wound healing, decompression sickness, infection, and gas embolism) and North America, Europe, Asia Pacific, and Rest of the World.

Image-Based Cytometer Market Top Scenario, SWOT Analysis, Business Overview, Forecast 2027

Image-Based Cytometer Market Overview

Cell cultivation in an indispensable part for applications within medicine and scientific investigation. From simple substance test to cell therapies, cell technologies are completely based on the controlled propagation of cells. To achieve this goal non-invasive characterization of the cell population is to be established. Microscope is the oldest piece of equipment required for cell culture but with the advances in technology, these are now automated microscopes combined with computerized image analysis. But image-based cytometry is much more capable than just describing cell cultures in terms of numbers.

Image-based Cytometer Market: Drivers and Restraints

The demand for image-based cytometer is expected to propel due to technological advancements, increasing use of image-based cytometer in clinical trials, development of intuitive software and the growing utilization of image-based flow cytometers in research activities. The Jefferson Trust, awarded US$ 775,000 to universities to engage faculty and students in research. Mass Cytometry Antibody Bank was awarded US$ 35,000, q new technology which simultaneously measures 100 different cellular attributes of thousands of individual cells. The major hurdle for the researchers to access such technologies is the high cost related to buying antibodies. Through this funding, this hurdle was overcame and could act as support for future donations.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-3543

Image-based Cytometer Market: Overview

High throughput screening is available in almost all the recent technologies introduced. This is because of the emerging trend towards precision medicine where each clinical trial is towards a specific cell. Thus cell analyzer are also developed such as they provide the researcher with multifunctional results of thousands of cells. With the increasing research undertakings and the potential offered for the equipment related the demand for image-based cytometer market is expected to propel. Moreover, market players are expanding their presence by developing a new technology or by growing in emerging countries.

Image-based Cytometer Market: Region-wise Outlook

In terms of geography, image-based cytometer market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America is expected to remain the dominating region while Asia Pacific is expected to emerge as a fastest growing region. ChemoMetec A/S established its first international sales subsidiary in Australia to be closer to its customer and addressing the issues quickly.

Image-based Cytometer Market: Key Market Participants

Some of the image-based cytometer market participants are Invitrogen, ChemoMetec A/S, Nexcelom Bioscience LLC., Vala Sciences Inc., Merck KGaA, GE Healthcare, Yokogawa Electric Corporation and Thorlabs, Inc.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-3543

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Image-based Cytometer Market: Segmentation

On the basis of application the image-based cytometer market can be segment as:

  • Research
  • Clinical
  • Others

On the basis of end user the image-based cytometer market can be segment as:

  • Hospital
  • Commercial Organizations
  • Clinical Testing Labs
  • Others

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/3543

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Neurointerventional Devices Market Research Report- Opportunities & Challenges With Completely Different Segments, Forecast- 2030

A new report by Future Market Insights (FMI) expects global neurointerventional devices market to grow at 7.8% CAGR through 2030. According to the study, the market will reach USD 5 billion in revenues by the end of 2030.

Since the past several years, the burden of neurological disorders has increased multifold. According to the National Center for Biotechnology Information (NCBI), the frequency of cerebral aneurysm is nearly 3.2%, with the prevalence being higher amongst women than men above 50 years of age.

It is estimated that around 6.5 million people in the United States possess an unruptured brain aneurysm, while 30,000 suffer a brain aneurysm rupture every year. Based on these trends, it is unsurprising to observe the market being interspersed with the presence of several reputed manufacturers who constantly launch new products.

In addition, rising prevalence of ischemic stroke is also boosting the neurointerventional devices market. Being non-invasive in nature, these devices increase chances of survival during surgery, further fueling market growth. By 2030, a valuation of US$ 4.8 Bn is predicted for the market.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-871

Global Neurointerventional Devices Market- Key Takeaways

  • North America shall be the market hegemon, holding a 40.7% market share from 2020-2030
  • Embolic coils to capture the majority share, carotid stents to surge in popularity
  • High incidence of cerebral aneurysm to accelerate adoption of coiling procedures
  • Presence of experienced surgeons shall accelerate hospital-grade neurointerventional device adoption

COVID-19’s Impact on the Market

With respect to neurological disorders, several hospitals and clinics have reported complications in severely or critically ill patients with co-morbidities. COVID-19 has the potential to affect the central and peripheral nervous systems. The virus invades the brain either through the olfactory system or a hematogenous route. Once inside, the virus may cause hypoxic and metabolic abnormalities.

In this light, the neurointerventional devices market is poised to remain afloat in the near-term forecast period. Significant increases in mechanical thrombectomies were reported since April 2020, with majority of the patients seeking treatment for acute strokes from large vessel occlusions (LVOs).

A series of case studies on over 200 COVID-19 positive patients in Wuhan, China, 36.4% of patients exhibited neurologic symptoms such as acute cerebrovascular events, muscle injury and impaired consciousness. In this context, the market is poised to experience an adrenaline rush in the short-run.

Competitive Intelligence

Some influential vendors within the landscape include: Stryker Corporation, Covidien Public Ltd., Penumbra Inc., Terumo Corporation, Johnson & Johnson Private Limited, Medtronic PLC, Boston Scientific Corporation and Abbott.

Players are emphasizing on expanding their businesses through partnerships, collaborations and mergers & acquisitions and participation in trade fairs. Many of them are also aligning with research institutes to augment their research capacities.

In August 2020, Stryker Corporation successfully launched its Surpass Evolve flow diverter after receiving FDA clearance in the U.S market. The device has already been in use in Europe since 2019.

In September 2020, Penumbra Inc. shall participate in the virtual Global Embolization Symposium & Technologies 2020 Conference. The company hopes to broaden its outreach and collaborate with other leading players to develop and launch new neurointerventional devices, thus expanding its existing product portfolio.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-871

More Insights into the Neurointerventional Devices Market

A recent market study published by FMI on the digital wound measurement devices market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. Our analysts have conducted thorough research on the historical as well as current growth parameters of the market to obtain growth prospects with maximum precision.

3D Orthopedic Scanning Systems Market Outlook 2022 Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2027

3D orthopedic scanning systems are advanced technology driven systems which are used for scanning individual’s body parts to help diagnose and treat the defect in it. The 3D orthopedic scanning systems through its scanning abilities help in designing customized items for individual and is finding increasing application in surgical practices. These 3D scanning orthopedic scanning systems are used in the development of footwear and scanning for medical and other research purposes. The current 3D scanning systems available are equipped with scanner, camera, display and data storing capacities.

3D Orthopedic Scanning Systems Market: Drivers and Restraints

3D orthopedic scanning systems saves a lot of time and paperwork and is the need of the current healthcare system. The hospitals are flooded with patients who need to undergo scanning. Moreover, with the aging population the number of orthopedic issues also is on a rise. According to the CDC data, from 2013-2015 around 54.4 million of US adult population have been ever told that they have got some form of rheumatoid arthritis, arthritis, lupus, gout, or fibromyalgia. Another factor driving the 3D orthopedic scanning market is the rising concern of the radiation exposure from multi detector computed tomography (CT). The implementation of iterative reconstruction software helps reduce radiation exposure while improving image quality.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-3542

3D Orthopedic Scanning Systems Market: Overview

Initiative such as Civilian American and European Surface Anthropometry Resource (CAESAR study) has been carried out with the aim to create databases of scans of various body parts which can be used for the manufacture of various products and devices. The 3D orthopedic scanning system market is experiencing a number of new market entrant who are establishing biomedical 3D printing startups through securing investments from several private investors. Axial 3D founded in 2014, received an investment of US$ 450,000 to contribute towards the U.S. and European medical industries. The Axial 3D was developed with the objective of reducing the time spent on surgery and saving US$ 7500 on each patient’s postoperative care.

3D Orthopedic Scanning Systems Market: Region-wise Outlook

The report covers market scenario for North America, Europe, Asia Pacific, Latin America and MEA. North America dominated the 3D orthopedic scanning market as there are various private investors and companies who are investing on the 3D scanning systems developed. Moreover, there is a strong reimbursement framework if any device needs to find its way into the healthcare setting. For instance, Medicare needs prior accreditation of the device before it is ready for reimbursement and for physicians they have to follow the radiology benefit manager’s guidelines. Asia Pacific is predicted to be the fastest growing region with the increasing foreign tourism and incidence rate of orthopedic issues.

3D Orthopedic Scanning Systems Market: Key Market Participants

Few manufacturers of the 3D orthopedic scanning systems market are Elinvision, Artec Europe, Orthopaedic Innovation Centre, Fuel 3D Technologies Limited, TechMed 3D Inc., FARO Technologies UK Ltd., 3D Systems, Inc., SCANNY3D S.R.L. and AGE Solutions S.r.l.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-3542

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

3D Orthopedic Scanning Systems Market: Segmentation

3D orthopedic scanning systems market is classified on the basis of product type, application and region.

Based on product type the 3D orthopedic scanning systems market is segmented into the following:

  • Scanning system
  • Software
  • Accessories

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/3542

Based on application the 3D orthopedic scanning systems market is segmented into the following:

  • Spine
  • Dental
  • Maxillofacial
  • Cosmetic Surgeries
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Preclinical Imaging Market Size 2022 Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2027

Preclinical Imaging is used for imagining of living animals specifically for research purposes, research can be for drug development and other types. Imaging products are very important so as to observe the changes in organs, cell or a tissue these changes are observed in animals that respond to environmental changes or physiological changes. Imaging modalities are mostly non-invasive and in vivo and are considered to be important for studying animal. There are different types of modalities which are used for preclinical imaging such as CT imaging, MRI imaging, PET/SPECT imaging, multimodal imaging, optical imaging, ultrasound imaging, and photoacoustic (PAT) imaging. Apart from above factors preclinical imaging market has huge growth potential and is expected to continue over the forecast period. Technological advancement in preclinical imaging and the increasing adoption of molecular imaging technology for drug development tool are some factors that are expected to drive the preclinical imaging market over the forecast period. Moreover, companies are into collaborations with the biotechnology and pharmaceutical companies to increase its geographical footprint globally which is expected to drive the global preclinical imaging market over the forecast period.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-2816

Preclinical Imaging Market: Drivers and Restraints

The demand for preclinical imaging market is fueled by technical innovation and discretionary funding which is thereby expected to drive the demand for preclinical imaging market over the forecast period. In addition the increasing number of clinical research organizations (CROs), research and development institutes, biotechnology and pharmaceuticals companies and other end users are propelling demand for preclinical imaging products. Encouragement for research and development, huge investments by government for research and need for drug development is expected to witness robust market growth during the forecast period. Moreover increasing applications such as life sciences, cosmetic industry and others for preclinical products is another factor that is expected to drive growth of the global preclinical imaging market over the forecast period. However, high cost of preclinical imaging systems and lack of awareness regarding preclinical imaging technology is expected to impede revenue growth of the preclinical imaging market over the forecast period.

Preclinical Imaging Market: Overview

The preclinical imaging market, is largely penetrated by some global players and these players are creating opportunities for the tier 2 and tier 3 players by withdrawing their products from the market. Moreover the major players in the market are focusing on introducing technological advance products. Above mentioned factors are expected to witness robust CAGR over the forecast period. Moreover, increasing research and development for drug development and for identification of unknown agents that causes death is expected to fuel demand for preclinical imaging products such as CT, MRI and others.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-2816

Preclinical Imaging Market: Regional Overview

Geographically, the global Preclinical Imaging Market, is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, Middle East and Africa (MEA).

North America dominates the global preclinical imaging market followed by Europe. North America and Western Europe regions are expected to witness robust growth due to increase in research and development and with the number of developed research infrastructure is expected to fuel the revenue growth in these regions. APEJ is expected to witness significant growth as compared to other regions and countries owing to government programs for preclinical imaging and funding for research and development expected to fuel market growth in this region. Moreover, rapidly expanding contract research organization in this region is expected to have a significant impact on the market growth.  However, increasing research and educational institutes may boost the growth of preclinical imaging market in these regions during the forecast period.

Preclinical Imaging Market: Key Players

Some of the players operating in the market for preclinical imaging market are Bruker Corporation, Thermo Fisher Scientific, General Electric, PerkinElmer, Inc., VisualSonics, Inc., MILabs B.V., Siemens A.G., TriFoil Imaging, Mediso Ltd., and Agilent Technologies and others.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/2816

Preclinical Imaging Market: Segmentation

The global preclinical imaging market, is segmented on the basis of product type, by application, by end user and region.

Segmentation by Product Type

  • Medical Devices
  • CT Imaging
  • MRI Imaging
  • PET/SPECT Imaging
  • Multimodal Imaging
  • Optical Imaging
  • Ultrasound Imaging
  • Photoacoustic (PAT) Imaging
  • Reagents
  • Services

Segmentation by Applications

  • Oncology
  • Neurology
  • Cardiology
  • Inflammation
  • Infectious diseases

Segmentation by End User

  • Hospitals
  • Clinics
  • Research Institutes

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Veterinary Injectable Devices Market Research Report- Opportunities & Challenges With Completely Different Segments, Forecast- 2027

Animals have always been a part of human life and they still play an important role in human life. It is important to keep the animals healthy. If animals are not healthy diseases can spread to humans also. Generally, drugs are administered to animals using injections. As injection are easy to be given to animals as compared to oral route and also this route of administration shows rapid action.

Veterinary Injectable Devices Market: Drivers and Restraints

Increasing prevalence of various diseases among animals is driving the growth of veterinary injectable devices market. Companion animals have become a part of people’s life and healthcare expenditure on these animals have increases. Increased healthcare expenditure to keep the companion animal healthy is driving the growth of injectable devices market. Increasing regulatory approval of injectable drugs for animal health is also boosting veterinary injectable devices market.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-4048

Veterinary Injectable Devices Market: Overview

Veterinary injectable devices market is expected to show significant growth over the forecast period. Increasing prevalence of various disease among animals and healthcare expenditure are factors which are driving the growth of veterinary injectable devices. Poultry and farm animals are always a higher risk of getting disease as compared to companion animals. If a spread among farm animals or poultry it can be life threatening for all the animals as well as for humans also. Death of farm animals and poultry will lead to financial loses. So vaccination is done among farm animals to prevent them from disease and which will lead to increased sales of veterinary injectable devices. Syringes and needles are the highest revenue generating segments of veterinary injectable devices and are expected to be continuing to dominate the veterinary injectable devices market over the forecast period. Market of needle free veterinary injectable system is increasing and expected to show significant growth over the forecast period. Plastic is the material of choice for the veterinary injectable devices as it is used for manufacturing of disposable injectable devices. Plastic segment is expected to keep dominating the veterinary injectable devices market due to low price and increased used of disposable injections.

Veterinary Injectable Devices Market: Region Wise Outlook

Geographically, the global veterinary injectable devices market can be segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. North America is most attractive and highest revenue generating veterinary injectable devices market due to better veterinary healthcare facilities and increased expenditure on companion animals. North America is one of the biggest meat consuming market and there are strict laws regarding this that meat should be from healthy anima. Asia Pacific is expected to be fastest growing veterinary injectable devices market over the forecast period due to increasing animal healthcare infrastructure and presence of large no of farm animals and big poultry businesses.

Veterinary Injectable Devices Market: Key Players

Some of the market participants in the global veterinary injectable devices market are Hamilton Company, Neogen Corporation, Micrel Medical Devices SA, Serumwerk Bernburg AG, PBS Animal Health, Medtronic Public Limited Company and Allflex USA, Inc. Major focus of these companies is on development of disposable and needle free syringes.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and grades.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2012 – 2016
  • Market Size & Forecast 2017 to 2027
  • Supply & Demand Value Chain
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis for Market includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific & Japan
  • The Middle East and Africa

Veterinary Injectable Devices Market: Segmentation

The global veterinary injectable devices market can be segmented on the basis of product type, material type, end user and geography.

On the basis of product type the global veterinary injectable devices market can be segmented into:

  • Syringes
  • Needles
  • Needle Free Injection System
  • Others

On the basis of material type the global veterinary injectable devices market can be segmented into:

  • Plastic
  • Glass
  • Metals

On the basis of end user the global veterinary injectable devices market can be segmented into:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Animal Research Institutes

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-4048

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.